Get startedLog in
    Picture of Agios Pharmaceuticals logo

    AGIO — Agios Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMid CapNeutral
    All News

    Brief: Avanzanite Bioscience’S Partner Agios Announces Pyrukynd® (Mitapivat) Approval In EU

    Picture of Agios Pharmaceuticals logoAgios Pharmaceuticals
    22/05/2026 15:38
    May 22 (Reuters) - Avanzanite Bioscience B.V:

AVANZANITE BIOSCIENCE’S PARTNER AGIOS ANNOUNCES PYRUKYND® (MITAPIVAT) APPROVAL IN THE EUROPEAN UNION FOR ADULTS WITH THALASSAEMIA

Source text: ID:nBws6nRza

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Agios Pharmaceuticals

    See all news